Open AccessCan 2 Different Fecal Calprotectin Assays be Used Interchangeably in IBD Treatment?
Author(s) -
Elsa A. van Wassenaer,
Kay Diederen,
Ester M. M. van Leeuwen,
Geert DʼHaens,
Marc A. Benninga,
Bart Koot,
Angelika Kindermann
Publication year - 2020
Publication title -
journal of clinical gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.141
H-Index - 112
eISSN - 1539-2031
pISSN - 0192-0790
DOI - 10.1097/mcg.0000000000001460
Subject(s) - calprotectin , medicine , interquartile range , confidence interval , inflammatory bowel disease , feces , gastroenterology , ulcerative colitis , biomarker , population , faecal calprotectin , immunology , disease , paleontology , biochemistry , chemistry , environmental health , biology
Fecal calprotectin (FC) is a biomarker for inflammation in inflammatory bowel disease (IBD). Interpretation of results can be complicated because of the use of different assays to determine FC.